Skip to main content
logo
SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,245.00
+6.00 (0.48%)
At close: Aug 3, 2026

SAMSUNG PHARM. Co., LTD. Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2018FY 2017FY 2016
Period EndingDec '24 Dec '24 Dec '23 Dec '18 Dec '17 Dec '16
Revenue
44,29444,29451,95546,48441,91947,194
Revenue Growth
-1.90%-14.74%11.77%10.89%-11.18%11.93%
Gross Profit
44,29444,29451,9558,5805,0698,770
Operating Income
14,82914,82918,037-5,399-7,774-6,327
Net Income
12,71112,71124,812-2,076-7,540-21,618
Earnings Per Share
----40.51-189.00-660.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2018FY 2017FY 2016
Period EndingDec '24 Dec '24 Dec '23 Dec '18 Dec '17 Dec '16
Cash & Investments
---33,41526,65712,409
Total Debt
---18,46045,36744,184
Net Cash (Debt)
---14,955-18,710-31,774
Net Cash Growth
------
Net Cash Per Share
---291.86-468.99-970.09

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2018FY 2017FY 2016
Period EndingDec '24 Dec '24 Dec '23 Dec '18 Dec '17 Dec '16
Operating Cash Flow
----6,5215,152-9,941
Capital Expenditures
----2,614-6,108-33,236
Free Cash Flow
----9,134-956.01-43,177
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2018FY 2017FY 2016
Period EndingDec '24 Dec '24 Dec '23 Dec '18 Dec '17 Dec '16
Gross Margin
100.00%100.00%100.00%18.46%12.09%18.58%
Operating Margin
33.48%33.48%34.72%-11.62%-18.55%-13.41%
Pretax Margin
28.70%28.70%45.57%-4.34%-26.16%-36.76%
Profit Margin
28.70%28.70%47.76%-4.46%-17.99%-45.80%
FCF Margin
----19.65%-2.28%-91.49%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2018FY 2017FY 2016
Period EndingAug '26 Dec '24 Dec '23 Dec '18 Dec '17 Dec '16
PE Ratio
9.2211.395.88---
PS Ratio
2.653.272.813.173.973.52